Previous radiotherapy and the clinical activity and toxicity of pembrolizumab in the treatment of non-small-cell lung cancer: a secondary analysis of the KEYNOTE-001 phase 1 trial
Shaverdian, Narek, MD, Lisberg, Aaron E, MD, Bornazyan, Krikor, MD, Veruttipong, Darlene, MPH, Goldman, Jonathan W, MD, Formenti, Silvia C, MD, Garon, Edward B, MD, Lee, Percy, Dr
Published in The lancet oncology (01.07.2017)
Published in The lancet oncology (01.07.2017)
Get full text
Journal Article
Updated Analysis From KEYNOTE-189: Pembrolizumab or Placebo Plus Pemetrexed and Platinum for Previously Untreated Metastatic Nonsquamous Non-Small-Cell Lung Cancer
Gadgeel, Shirish, Rodríguez-Abreu, Delvys, Speranza, Giovanna, Esteban, Emilio, Felip, Enriqueta, Dómine, Manuel, Hui, Rina, Hochmair, Maximilian J, Clingan, Philip, Powell, Steven F, Cheng, Susanna Yee-Shan, Bischoff, Helge G, Peled, Nir, Grossi, Francesco, Jennens, Ross R, Reck, Martin, Garon, Edward B, Novello, Silvia, Rubio-Viqueira, Belén, Boyer, Michael, Kurata, Takayasu, Gray, Jhanelle E, Yang, Jing, Bas, Tuba, Pietanza, M Catherine, Garassino, Marina C
Published in Journal of clinical oncology (10.05.2020)
Published in Journal of clinical oncology (10.05.2020)
Get full text
Journal Article
Phase 1/2 Study of the Safety and Tolerability of Nivolumab Plus Crizotinib for the First-Line Treatment of Anaplastic Lymphoma Kinase Translocation — Positive Advanced Non–Small Cell Lung Cancer (CheckMate 370)
Spigel, David R., Reynolds, Craig, Waterhouse, David, Garon, Edward B., Chandler, Jason, Babu, Sunil, Thurmes, Paul, Spira, Alexander, Jotte, Robert, Zhu, Jin, Lin, Wen Hong, Blumenschein, George
Published in Journal of thoracic oncology (01.05.2018)
Published in Journal of thoracic oncology (01.05.2018)
Get full text
Journal Article
Mutational landscape determines sensitivity to PD-1 blockade in non–small cell lung cancer
Rizvi, Naiyer A., Hellmann, Matthew D., Snyder, Alexandra, Kvistborg, Pia, Makarov, Vladimir, Havel, Jonathan J., Lee, William, Yuan, Jianda, Wong, Phillip, Ho, Teresa S., Miller, Martin L., Rekhtman, Natasha, Moreira, Andre L., Ibrahim, Fawzia, Bruggeman, Cameron, Gasmi, Billel, Zappasodi, Roberta, Maeda, Yuka, Sander, Chris, Garon, Edward B., Merghoub, Taha, Wolchok, Jedd D., Schumacher, Ton N., Chan, Timothy A.
Published in Science (American Association for the Advancement of Science) (03.04.2015)
Published in Science (American Association for the Advancement of Science) (03.04.2015)
Get full text
Journal Article
Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial
Herbst, Roy S, Prof, Baas, Paul, Prof, Kim, Dong-Wan, MD, Felip, Enriqueta, MD, Pérez-Gracia, José L, MD, Han, Ji-Youn, Prof, Molina, Julian, MD, Kim, Joo-Hang, Prof, Arvis, Catherine Dubos, MD, Ahn, Myung-Ju, Prof, Majem, Margarita, MD, Fidler, Mary J, MD, de Castro, Gilberto, MD, Garrido, Marcelo, MD, Lubiniecki, Gregory M, MD, Shentu, Yue, PhD, Im, Ellie, MD, Dolled-Filhart, Marisa, PhD, Garon, Edward B, MD
Published in The Lancet (British edition) (09.04.2016)
Published in The Lancet (British edition) (09.04.2016)
Get full text
Journal Article
Pembrolizumab Exposure-Response Assessments Challenged by Association of Cancer Cachexia and Catabolic Clearance
Turner, David C, Kondic, Anna G, Anderson, Keaven M, Robinson, Andrew G, Garon, Edward B, Riess, Jonathan Wesley, Jain, Lokesh, Mayawala, Kapil, Kang, Jiannan, Ebbinghaus, Scot W, Sinha, Vikram, de Alwis, Dinesh P, Stone, Julie A
Published in Clinical cancer research (01.12.2018)
Published in Clinical cancer research (01.12.2018)
Get full text
Journal Article
Biophysical isolation and identification of circulating tumor cells
Che, James, Yu, Victor, Garon, Edward B, Goldman, Jonathan W, Di Carlo, Dino
Published in Lab on a chip (11.04.2017)
Published in Lab on a chip (11.04.2017)
Get full text
Journal Article
Continuous Versus 1-Year Fixed-Duration Nivolumab in Previously Treated Advanced Non-Small-Cell Lung Cancer: CheckMate 153
Waterhouse, David M, Garon, Edward B, Chandler, Jason, McCleod, Michael, Hussein, Maen, Jotte, Robert, Horn, Leora, Daniel, Davey B, Keogh, George, Creelan, Ben, Einhorn, Lawrence H, Baker, Justin, Kasbari, Samer, Nikolinakos, Petros, Babu, Sunil, Couture, Felix, Leighl, Natasha B, Reynolds, Craig, Blumenschein, Jr, George, Gunuganti, Vijay, Li, Ang, Aanur, Nivedita, Spigel, David R
Published in Journal of clinical oncology (20.11.2020)
Published in Journal of clinical oncology (20.11.2020)
Get full text
Journal Article
Using Multiplexed Assays of Oncogenic Drivers in Lung Cancers to Select Targeted Drugs
Kris, Mark G, Johnson, Bruce E, Berry, Lynne D, Kwiatkowski, David J, Iafrate, A. John, Wistuba, Ignacio I, Varella-Garcia, Marileila, Franklin, Wilbur A, Aronson, Samuel L, Su, Pei-Fang, Shyr, Yu, Camidge, D. Ross, Sequist, Lecia V, Glisson, Bonnie S, Khuri, Fadlo R, Garon, Edward B, Pao, William, Rudin, Charles, Schiller, Joan, Haura, Eric B, Socinski, Mark, Shirai, Keisuke, Chen, Heidi, Giaccone, Giuseppe, Ladanyi, Marc, Kugler, Kelly, Minna, John D, Bunn, Paul A
Published in JAMA : the journal of the American Medical Association (21.05.2014)
Published in JAMA : the journal of the American Medical Association (21.05.2014)
Get full text
Journal Article
Ramucirumab plus docetaxel versus placebo plus docetaxel for second-line treatment of stage IV non-small-cell lung cancer after disease progression on platinum-based therapy (REVEL): a multicentre, double-blind, randomised phase 3 trial
Garon, Edward B, Dr, Ciuleanu, Tudor-Eliade, Prof, Arrieta, Oscar, MD, Prabhash, Kumar, Prof, Syrigos, Konstantinos N, Prof, Goksel, Tuncay, Prof, Park, Keunchil, Prof, Gorbunova, Vera, MD, Kowalyszyn, Ruben Dario, MD, Pikiel, Joanna, MD, Czyzewicz, Grzegorz, MD, Orlov, Sergey V, Prof, Lewanski, Conrad R, MD, Thomas, Michael, Prof, Bidoli, Paolo, MD, Dakhil, Shaker, MD, Gans, Steven, MD, Kim, Joo-Hang, Prof, Grigorescu, Alexandru, Prof, Karaseva, Nina, MD, Reck, Martin, MD, Cappuzzo, Federico, MD, Alexandris, Ekaterine, MS, Sashegyi, Andreas, PhD, Yurasov, Sergey, MD, Pérol, Maurice, MD
Published in The Lancet (British edition) (23.08.2014)
Published in The Lancet (British edition) (23.08.2014)
Get full text
Journal Article
Knowledge Gaps and Research Priorities in Immune Checkpoint Inhibitor-related Pneumonitis. An Official American Thoracic Society Research Statement
Sears, Catherine R, Peikert, Tobias, Possick, Jennifer D, Naidoo, Jarushka, Nishino, Mizuki, Patel, Sandip P, Camus, Philippe, Gaga, Mina, Garon, Edward B, Gould, Michael K, Limper, Andrew H, Montgrain, Philippe R, Travis, William D, Rivera, M Patricia
Published in American journal of respiratory and critical care medicine (15.09.2019)
Published in American journal of respiratory and critical care medicine (15.09.2019)
Get full text
Journal Article
Immune Checkpoint Inhibitors in Thoracic Malignancies: Review of the Existing Evidence by an IASLC Expert Panel and Recommendations
Remon, Jordi, Passiglia, Francesco, Ahn, Myung-Ju, Barlesi, Fabrice, Forde, Patrick M., Garon, Edward B., Gettinger, Scott, Goldberg, Sarah B., Herbst, Roy S., Horn, Leora, Kubota, Kaoru, Lu, Shun, Mezquita, Laura, Paz-Ares, Luis, Popat, Sanjay, Schalper, Kurt A., Skoulidis, Ferdinandos, Reck, Martin, Adjei, Alex A., Scagliotti, Giorgio V.
Published in Journal of thoracic oncology (01.06.2020)
Published in Journal of thoracic oncology (01.06.2020)
Get full text
Journal Article
PointBreak: A Randomized Phase III Study of Pemetrexed Plus Carboplatin and Bevacizumab Followed by Maintenance Pemetrexed and Bevacizumab Versus Paclitaxel Plus Carboplatin and Bevacizumab Followed by Maintenance Bevacizumab in Patients With Stage IIIB or IV Nonsquamous Non–Small-Cell Lung Cancer
PATEL, Jyoti D, SOCINSKI, Mark A, GUBA, Susan C, JINGYI LIU, FRIMODT-MOLLER, Bente, JOHN, William J, OBASAJU, Coleman K, PENNELLA, Eduardo J, BONOMI, Philip, GOVINDAN, Ramaswamy, GARON, Edward B, REYNOLDS, Craig H, SPIGEL, David R, OLSEN, Mark R, HERMANN, Robert C, JOTTE, Robert M, BECK, Thaddeus, RICHARDS, Donald A
Published in Journal of clinical oncology (01.12.2013)
Published in Journal of clinical oncology (01.12.2013)
Get full text
Journal Article
Evaluation of PD-L1 expression on vortex-isolated circulating tumor cells in metastatic lung cancer
Dhar, Manjima, Wong, Jessica, Che, James, Matsumoto, Melissa, Grogan, Tristan, Elashoff, David, Garon, Edward B, Goldman, Jonathan W, Sollier Christen, Elodie, Di Carlo, Dino, Kulkarni, Rajan P
Published in Scientific reports (07.02.2018)
Published in Scientific reports (07.02.2018)
Get full text
Journal Article
Proteomic Analysis of Human Saliva From Lung Cancer Patients Using Two-Dimensional Difference Gel Electrophoresis and Mass Spectrometry
Xiao, Hua, Zhang, Lei, Zhou, Hui, Lee, Jay M., Garon, Edward B., Wong, David T.W.
Published in Molecular & cellular proteomics (01.02.2012)
Published in Molecular & cellular proteomics (01.02.2012)
Get full text
Journal Article
The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of non-small cell lung cancer (NSCLC)
Brahmer, Julie R, Govindan, Ramaswamy, Anders, Robert A, Antonia, Scott J, Sagorsky, Sarah, Davies, Marianne J, Dubinett, Steven M, Ferris, Andrea, Gandhi, Leena, Garon, Edward B, Hellmann, Matthew D, Hirsch, Fred R, Malik, Shakuntala, Neal, Joel W, Papadimitrakopoulou, Vassiliki A, Rimm, David L, Schwartz, Lawrence H, Sepesi, Boris, Yeap, Beow Yong, Rizvi, Naiyer A, Herbst, Roy S
Published in Journal for immunotherapy of cancer (17.07.2018)
Published in Journal for immunotherapy of cancer (17.07.2018)
Get full text
Journal Article
Role of race in oncogenic driver prevalence and outcomes in lung adenocarcinoma: Results from the Lung Cancer Mutation Consortium
Steuer, Conor E., Behera, Madhusmita, Berry, Lynne, Kim, Sungjin, Rossi, Michael, Sica, Gabriel, Owonikoko, Taofeek K., Johnson, Bruce E., Kris, Mark G., Bunn, Paul A., Khuri, Fadlo R., Garon, Edward B., Ramalingam, Suresh S.
Published in Cancer (01.03.2016)
Published in Cancer (01.03.2016)
Get full text
Journal Article
Sensitive detection of tumor mutations from blood and its application to immunotherapy prognosis
Li, Shuo, Noor, Zorawar S, Zeng, Weihua, Stackpole, Mary L, Ni, Xiaohui, Zhou, Yonggang, Yuan, Zuyang, Wong, Wing Hung, Agopian, Vatche G, Dubinett, Steven M, Alber, Frank, Li, Wenyuan, Garon, Edward B, Zhou, Xianghong Jasmine
Published in Nature communications (07.07.2021)
Published in Nature communications (07.07.2021)
Get full text
Journal Article
Clinical outcomes of ramucirumab plus docetaxel in the treatment of patients with non-small cell lung cancer after immunotherapy: a systematic literature review
Garon, Edward B., Visseren-Grul, Carla, Rizzo, Maria Teresa, Puri, Tarun, Chenji, Suresh, Reck, Martin
Published in Frontiers in oncology (04.09.2023)
Published in Frontiers in oncology (04.09.2023)
Get full text
Journal Article
Development of transcriptomic biomarker signature in human saliva to detect lung cancer
Zhang, Lei, Xiao, Hua, Zhou, Hui, Santiago, Silverio, Lee, Jay M., Garon, Edward B., Yang, Jieping, Brinkmann, Ole, Yan, Xinmin, Akin, David, Chia, David, Elashoff, David, Park, No-Hee, Wong, David T. W.
Published in Cellular and molecular life sciences : CMLS (01.10.2012)
Published in Cellular and molecular life sciences : CMLS (01.10.2012)
Get full text
Journal Article